News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
Commentary: Current evidence does not support call for more frequent colorectal cancer screening
In an editorial published in JAMA, UNC Lineberger's Hanna Sanoff, MD, MPH, evaluated two studies that investigated whether higher-intensity testing for non-metastatic colorectal cancer is more effective.
Symposium showcases career options for scientists-in-training
UNC Lineberger's second annual Integrated Training in Cancer Model Systems Director’s Career Symposium introduces scientists-in-training to a variety of career paths.
Bladder cancer model could pave the way for better drug efficacy studies
In the journal Cancer Research, UNC Lineberger’s William Y. Kim, MD, Benjamin G. Vincent, MD, and colleagues reported they have developed a mouse model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer. The researchers said this model may help them to determine which patients may respond to immunotherapy treatments called checkpoint inhibitors.
Knowledge of e-cigarette health risk doesn't deter teen use, survey shows
UNC Lineberger's Seth Noar, PhD, and colleagues found that the majority of teenagers they surveyed knew about many of the health risks of e-cigarettes, but it had no influence on whether they had used e-cigarettes. However, they determined beliefs about addiction were a key discriminating factor among those who had and had not used e-cigarettes.
Roth, Johnson awarded $28 million for Illuminating Druggable Genome NIH grants
The grants are part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.